Streetbeat News

Regulatory

X

Vice President Harris announced plans to offer tax credits to boost investments in steel and iron manufacturing. The initiative aims to prioritize strengthening and retooling factories.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 8:04 pm

NCNA

NuCana plc (NASDAQ:NCNA) has been granted a new composition-of-matter patent for its anti-cancer agent NUC-7738 by the USPTO. This strengthens its intellectual property portfolio, which includes over 80 patents globally. NUC-7738 is in Phase 2 trials for melanoma treatment.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 8:03 pm

LLY

NVO

A study suggests that Novo Nordisk's semaglutide, marketed as Ozempic and Wegovy, may reduce opioid overdose risk in diabetic opioid users. This potential new use for semaglutide could address the urgent need for alternative opioid use disorder therapies. Eli Lilly's dulaglutide, marketed as Trulicity, was also part of the study but did not show the same results. Further research is needed to validate these findings.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 7:59 pm

DE

Former President Donald Trump has threatened to impose a 200% tariff on John Deere products if the company shifts production from the U.S. to Mexico. This could negatively impact Deere & Co's stock price and investors, including some members of Congress. The threat has drawn criticism from figures like Mark Cuban, who argue it could harm the company. Deere shares are currently trading at $407.40.

Portfolio Pulse from Chris Katje

September 25, 2024 | 7:54 pm

BGNE

BMY

MRK

The FDA's Oncologic Drugs Advisory Committee is set to discuss the use of PD-1 cancer drugs from Merck, Bristol Myers, and BeiGene for certain gastric cancer patients. The FDA has raised concerns about the efficacy of these drugs for patients with low PD-L1 expression, suggesting that they may not benefit and could face severe side effects.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 7:54 pm

CRSP

VRTX

Health Canada has approved CASGEVY (Exagamglogene Autotemcel), the first CRISPR/Cas9 gene-edited therapy, for treating sickle cell disease and transfusion-dependent beta thalassemia in patients aged 12 and older. This approval marks a significant milestone in gene therapy.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:52 pm

SPY

The US is preparing $8 billion in arms aid packages for Ukraine, coinciding with President Zelenskiy's visit. This move is part of ongoing support for Ukraine amid its conflict with Russia.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:35 pm

AZN

The FDA has approved Osimertinib for the treatment of locally advanced, unresectable Stage III non-small cell lung cancer following chemoradiation therapy. The recommended dose is 80mg daily until disease progression or unacceptable toxicity.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:31 pm

EIS

ISRA

SPY

In a Fox News interview, White House's Kirby stated there is no indication that Iran is interested in an all-out war in the region. This statement may impact defense and geopolitical-related ETFs.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:25 pm

PYPL

PayPal has announced that its U.S. merchants can now buy, hold, and sell cryptocurrency directly from their PayPal business accounts. However, this feature will not be available in New York State at launch.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:16 pm